A novel fasting blood test for insulin resistance and prediabetes.
about
Personalized Cardiovascular Disease Prediction and Treatment-A Review of Existing Strategies and Novel Systems Medicine ToolsGlobal metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal diseaseComprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practiceMetabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.Can we trust untargeted metabolomics? Results of the metabo-ring initiative, a large-scale, multi-instrument inter-laboratory study.A novel test for IGT utilizing metabolite markers of glucose tolerance.A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic controlGenetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetesMetabolomics reveals dose effects of low-dose chronic exposure to uranium in rats: identification of candidate biomarkers in urine samples.Novel biomarkers for prediabetes, diabetes, and associated complications.Serum α-hydroxybutyrate (α-HB) predicts elevated 1 h glucose levels and early-phase β-cell dysfunction during OGTT.A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.Metabolomics toward personalized medicine.Evidence-based estimation of insulin resistance.Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults.Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations.Metabolomics for Biomarkers of Type 2 Diabetes Mellitus: Advances and Nutritional Intervention Trends
P2860
Q26767513-793A5BA1-B745-4366-9957-EB328FB04559Q34061753-12D2877E-279F-4814-8B8C-E34C1626D583Q34062993-40D42B2D-02C3-469C-966B-D6929A2B6315Q34527732-57FA2C58-A51D-4ECE-9289-7B62AE8D5687Q35578281-24A33896-F857-4786-B551-1FD9D5761890Q35763105-B5BFF2C1-9D12-462F-84F7-9084E1599042Q35830440-62AF3C9D-F2FF-4D09-BECC-5398B5C6380AQ35842441-2E1CB4BE-716F-4601-A347-8E0167E3860AQ36867636-D0B90E7E-822F-4FF0-9D0D-BFA6D1AC2B9DQ37260270-825605D2-212B-4D8D-8F1E-984C9BEC5E54Q41475816-607F967D-2E7E-4CDE-B4E4-F760F2574444Q42966193-734F4C77-F3CA-4283-80D7-B4600DDFBE52Q50084091-19B9525B-1491-4D0E-AC5D-58D9B6834B34Q50090010-B64960C9-77D1-47BA-AD96-BE4CD8C26274Q51318892-C9E87F43-C2C2-47E1-A7ED-2C6243753549Q52648008-162000D5-5D9B-4404-87AF-C6D7A33A9F99Q53367555-E464A98E-336D-40B8-8514-9A6103EDDE96Q55290300-67546583-C7FB-45FC-BB56-A2E61F4DF61BQ58419488-34734518-377F-421F-A4EB-CB7739AFD193
P2860
A novel fasting blood test for insulin resistance and prediabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel fasting blood test for insulin resistance and prediabetes.
@en
type
label
A novel fasting blood test for insulin resistance and prediabetes.
@en
prefLabel
A novel fasting blood test for insulin resistance and prediabetes.
@en
P2093
P2860
P1476
A novel fasting blood test for insulin resistance and prediabetes
@en
P2093
Ele Ferrannini
Eric Button
James Hathorn
Kay Lawton
Klaus-Peter Adam
Michael Milburn
Pamela Nakhle
Regis Perichon
Walter Gall
P2860
P304
P356
10.1177/193229681300700112
P577
2013-01-01T00:00:00Z